Mr Yuichiro Kondo is a Project Leader at Nephrology R&D Management Office, Nephrology Unit, R&D Division Kyowa Kirin Co., Ltd. Japan. He is Responsible for the management of the R&D project of evocalcet and in charge of many CKD-MBD projects.
More about Yuichiro Kondo
April 2013-March 2018
Pharmacological Researcher of CKD-MBD, renal anemia and CKD,
Nephrology research laboratory in Kyowa Kirin Co., Ltd.
Experience engaged in preclinical pharmacological research on many clinical trial candidates, marketing products and introduced products in CKD-MBD, renal anemia and CKD such as cinacalcet, evocalcet, VDRA, phosphate binder, anti-FGF23 antibody and ESA.
April 2009-March 2013
Pharmacological Researcher of bone diseases,
Pharmacological Research laboratory in Kyowa Kirin Co., Ltd.
Preclinical research on bone diseases.
2007 Bachelor of Engineering, Department of Applied Chemistry, Keio University
2009 Master of Engineering, Department of Chemical Biology, Keio University
Publications and Presentations
Kondo Y, et al. The effects of cinacalcet on vagus nerve in miniature pigs. Kidney and Dialysis (in Japanese). 2017; 82: 455-460
Kengo Yamawaki, Yuichiro Kondo, et al. The soluble form of BMPRIB is a novel therapeutic candidate for treating bone related disorders. Scientific Reports. 2016; 6:18849
The effects of cinacalcet on vagus nerve in miniature pigs. Oral presentation in topic session, JAPAN CKD-MBD FORUM,?and oral presentation in oral session, JSDT in 2017
The novel oral calcimimetic, evocalcet. Invited speaker KSN 2019 in Korea
Japanese Society of Dialysis and Transplantation JSDT